Puy L A, Asa S L
Department of Pathology, Mount Sinai Hospital, University of Toronto, Canada.
Neuroendocrinology. 1996 Apr;63(4):349-55. doi: 10.1159/000126975.
Pit-1 expression has been reported to be cell-type-specific in the adult human pituitary and in human pituitary adenomas. In contrast, studies of rodent fetal adenohypophysial development as well as mature rodent glands have indicated that the pit-1 mRNA is ubiquitously expressed and the protein is under translational control. To determine the ontogeny and localization of Pit-1 expression in the human fetus, we examined fetal pituitaries (n = 23) at various stages of gestation from 6 weeks to term using in situ hybridization (ISH) for pit-1 mRNA, immunohistochemical localization of Pit-1 protein, and combined ISH for pit-1 mRNA with immunohistochemistry for pituitary hormones. At 6 and 7 weeks of gestation, the cells surrounding both limbs of Rathke's cleft showed a moderate specific signal for pit-1 mRNA. At 7 weeks, only a few cells were immunoreactive for ACTH and there was no definite colocalization of that hormone with pit-1 mRNA. At 8 and 9 weeks of gestation, there was definite preferential expression of pit-1 mRNA in cells containing growth hormone (GH) but not ACTH, as well as in cells with no detectable hormone immunopositivity. At midgestation and after, there was clear correlation between pit-1 mRNA expression and hormone content; cells with GH, prolactin and/or thyrotropin immunoreactivity had abundant pit-1 mRNA, whereas those containing ACTH, FSH or LH were negative for pit-1 mRNA by ISH and its protein by immunohistochemistry. The signal for pit-1 mRNA was stronger in intensity and present in more cells in fetal than in adult adenohypophyses. The ontogeny of pit-1 mRNA expression indicates that it precedes the onset of pituitary hormone detection. Its abundance in the human pituitary early in gestation may reflect its role in cytodifferentiation and cell proliferation. The correlation between pit-1 mRNA detection and Pit-1 protein localization is consistent with a cell-type-specific pretranslational regulatory mechanism for Pit-1 expression in the developing human adenohypophysis.
据报道,Pit-1在成人垂体和垂体腺瘤中呈细胞类型特异性表达。相比之下,对啮齿动物胎儿腺垂体发育以及成熟啮齿动物腺体的研究表明,pit-1 mRNA普遍表达,其蛋白质处于翻译控制之下。为了确定人类胎儿中Pit-1表达的个体发生和定位,我们使用原位杂交(ISH)检测pit-1 mRNA、Pit-1蛋白的免疫组化定位以及pit-1 mRNA原位杂交与垂体激素免疫组化相结合的方法,对23例不同孕周(从6周妊娠到足月)的胎儿垂体进行了检查。在妊娠6周和7周时,Rathke裂沟两侧肢体周围的细胞对pit-1 mRNA显示出中等强度的特异性信号。在7周时,只有少数细胞对促肾上腺皮质激素(ACTH)呈免疫反应性,且该激素与pit-1 mRNA没有明确的共定位。在妊娠8周和9周时,pit-1 mRNA在含有生长激素(GH)而非ACTH的细胞以及未检测到激素免疫阳性的细胞中呈明确的优先表达。在妊娠中期及之后,pit-1 mRNA表达与激素含量之间存在明显相关性;具有GH、催乳素和/或促甲状腺激素免疫反应性的细胞具有丰富的pit-1 mRNA,而通过原位杂交检测含ACTH、促卵泡激素(FSH)或促黄体生成素(LH)的细胞以及通过免疫组化检测其蛋白质时呈阴性。pit-1 mRNA的信号强度在胎儿腺垂体中比成人腺垂体更强且存在于更多细胞中。pit-1 mRNA表达的个体发生表明其先于垂体激素检测的开始。其在妊娠早期人类垂体中的丰度可能反映了其在细胞分化和细胞增殖中的作用。pit-1 mRNA检测与Pit-1蛋白定位之间的相关性与发育中的人类腺垂体中Pit-1表达的细胞类型特异性翻译前调节机制一致。